ulcerative colitis
-
Aurobindo’s subsidiary CuraTeQ obtains exclusive rights for BioFactura’s Ustekinumab biosimilar
CuraTeQ has been granted exclusive license rights to commercialize BFI-751 in all major regulated markets including the US, the EU,…
Read More » -
Zydus Cadila gets tentative US FDA nod for ulcerative colitis drug
The medication is suggested for the once-daily treatment of adult patients with moderate to severe active ulcerative colitis Zydus Cadila…
Read More »